(S (NP (NP (NNP Ultrasound)) (PRN (-LRB- -LRB-) (NP (NNP US)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB commonly)) (VBN used)) (NN liver) (VBG imaging) (NN modality)) (ADVP (NN worldwide)))) (. .))
(S (PP (JJ Due) (TO to) (NP (PRP$ its) (JJ low) (NN cost))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB increasingly)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN follow-up)) (PP (IN of) (NP (NP (NN cancer) (NNS patients)) (PP (IN with) (NP (NP (NNS metastases)) (VP (VBN localized) (PP (IN in) (NP (DT the) (NN liver)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN contribution))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (DT an) (JJ interactive) (NN segmentation) (NN approach)) (PP (IN for) (NP (NN liver) (NNS metastases))) (PP (IN in) (NP (NNP US) (NNS acquisitions))))))) (. .))
(S (NP (DT A) (PRN (-LRB- -LRB-) (NN semi-) (-RRB- -RRB-)) (JJ automatic) (NN segmentation)) (VP (VBZ is) (ADVP (RB still)) (ADJP (RB very) (JJ challenging)) (PP (IN because) (IN of) (NP (NP (DT the) (JJ low) (NN image) (NN quality)) (CC and) (NP (NP (DT the) (JJ low) (NN contrast)) (PP (IN between) (NP (NP (DT the) (NN metastasis)) (CC and) (NP (DT the) (VBG surrounding) (NN liver) (NN tissue)))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN state)) (PP (IN of) (NP (DT the) (NN art))) (PP (IN in) (NP (JJ clinical) (NN practice)))) (VP (VBZ is) (ADVP (RB still)) (NP (NP (JJ manual) (NN measurement) (CC and) (NN outlining)) (PP (IN of) (NP (DT the) (NNS metastases))) (PP (IN in) (NP (DT the) (NNP US) (NNS images))))) (. .))
(S (NP (PRP We)) (VP (VBP tackle) (NP (DT the) (NN problem)) (PP (IN by) (S (VP (VBG providing) (NP (NP (DT an) (JJ interactive) (NN segmentation) (NN approach)) (VP (VBG providing) (NP (NP (JJ real-time) (NN feedback)) (PP (IN of) (NP (DT the) (NN segmentation) (NNS results)))))))))) (. .))
(S (S (NP (DT The) (NN approach)) (VP (VBZ has) (VP (VBN been) (VP (VBN evaluated) (PP (IN with) (NP (NP (JJ typical) (NNP US) (NNS acquisitions)) (PP (IN from) (NP (DT the) (JJ clinical) (NN routine))))))))) (, ,) (CC and) (S (NP (DT the) (NNS datasets)) (VP (VBD consisted) (PP (IN of) (NP (JJ pancreatic) (NN cancer) (NNS metastases))))) (. .))
(S (PP (ADVP (RB Even)) (IN for) (NP (JJ difficult) (NNS cases))) (, ,) (NP (VBG satisfying) (NNS segmentations) (NNS results)) (VP (MD could) (VP (VB be) (VP (VBN achieved) (PP (IN because) (IN of) (NP (NP (DT the) (JJ interactive) (JJ real-time) (NN behavior)) (PP (IN of) (NP (DT the) (NN approach)))))))) (. .))
(S (PP (IN In) (NP (JJ total))) (, ,) (NP (CD 40) (JJ clinical) (NNS images)) (VP (VBP have) (VP (VBN been) (VP (VBN evaluated) (PP (IN with) (NP (PRP$ our) (NN method))) (PP (IN by) (S (VP (VBG comparing) (NP (DT the) (NNS results)) (PP (IN against) (NP (JJ manual) (NN ground) (NN truth) (NNS segmentations))))))))) (. .))
(S (NP (DT This) (NN evaluation)) (VP (VBD yielded) (PP (TO to) (NP (NP (NP (DT an) (JJ average) (NNP Dice) (NNP Score)) (PP (IN of) (NP (CD 85) (NN %)))) (CC and) (NP (NP (DT an) (JJ average) (NNP Hausdorff) (NNP Distance)) (PP (IN of) (NP (CD 13) (NNS pixels))))))) (. .))
